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Rabbits were, given 1.14 mg nicotine per kg body weight twice daily for 20 months. The following results were obtained:
1. Total cholesterol, total lipids, esterified fatty acids and phospholipids are increased towards the middle of the experiment and
approximate to the starting values at the end of the experiment. There are no differences between nicotine-treated animals and controls.
2. Free fatty acids in the blood of nicotine-treated animals are elevated after 8 months, less so after 12 months and the same as the con-
trols after 20 months; these changes, however, are not statistically significant. The qualitative composition of the esterified fatty acids
in the blood of the nicotine-treated animals sho\vs no difference as compared to the controls.
3. ß-Lipoproteins and /?-lipoprotein cholesterol in the blood of the nicotine-treated animals were not increased after 20 months.
4. In nicotine-treated animals, the above lipids show no increase in heart, liver and aorta, with the exception of free fatty acids, which
are elevated in liver and aorta. In the liver, the neutral fat is significantly decreased in nicotine-treated animals.
5. The activity of lipoprotein lipase is intensively increased in heart and aorta of the nicotine-treated group.
6. The content of calcium in the aorta of the nicotine-treated group is significantly increased.
7. Histologically changes are observed, which in addition to other pathological findings, show a tendency to develop arteriosclerosis,
but these changes could be observed in the nicotine treated and the control group with the same frequency and to the same extent.
8. When the animals were sacrificed after 20 months, the following further results were obtained:
In the blood of the test animals, no alterations were observed in: serum enzymes, proteins, red and white blood cell count, electrolyte
content, level of urea and blood sugar.
9. It is concluded from these results: Statistical-epidemiological correlations between the morbidity of coronary heart disease and
cigarette smoking can not be explained by the pharmacological effect of nicotine alone, which, through the release of catecholamines,
is lipolytic. Investigations on further smoke constituents are indicated with regard to coronary heart disease.
Kaninchen erhielten während 20 Monate 1,14 mg/kg Nikotin 2mal täglich, die folgenden Ergebnisse wurden erhalten:
1. Im Blut sind das Gesamtcholesterin, Gesamtlipide, die veresterten Fettsäuren und die Phosphatide nach 12 Monaten erhöht und sind
gegen Ende des Experimentes wieder gleich den Ausgangswerten. Unterschiede zwischen den nikotinbehandelten und den Kontroll-
tieren bestehen nicht.
2. Die freien Fettsäuren im Blut der nikotinbehandelten Tiere waren nach 8 Monaten erhöht, nach 12 Monaten weniger stark erhöht
und gleich denen der Kontrollen nach 20 Monaten. Dieser Unterschied war statistisch nicht signifikant. Die qualitative Zusammen^
Setzung der veresterten Fettsäuren im Blut der nikotinbehandelten Tiere war nicht verschieden von derjenigen der Kontrollen.
3. jÖ-Lipoproteine und ß-Lipoproteincholesterin waren nach 20 Monaten nicht verschieden zwischen beiden Gruppen.
4. Die erwähnten Lipoide waren nicht erhöht in Herz, Leber und Aorta der nikotinbehandelten Tiere, mit Ausnahme der freien Fett-
säuren, welche in Leber und Aorta signifikant erhöht waren. In der Leber der behandelten Tiere war der Neutralfettgehalt erniedrigt.
5. Die Aktivität der Lipoproteinlipase war erhöht in Herz und Aorta der behandelten Tiere.
6. Der Calciumgehalt der Aorta der behandelten Tiere war erhöht.
7. Histologisch konnten Veränderungen beobachtet werden, welche, neben anderen pathologischen Befunden, die Tendenz zur Ent-
wicklung einer Arteriosklerose zeigten, diese Veränderungen wurden jedoch in behandelten und unbehandelten Tieren in der gleichen
Häufigkeit und dem gleichen Ausmaß beobachtet.
8. Nach Tötung der Tiere nach 20 Monaten wurden die folgenden weiteren Befunde erhoben:
Keine Veränderung wurde im Blut der nikotinbehandelten Tiere gefunden bei: Serumenzymen, Serumproteinen, rotem und weißem
Blutbild, Elektrolytgehalt, Harnstoffspiegel und Blutzuckerspiegel.
9. Es wird aus den Ergebnissen geschlossen: Statistisch-epidemiologische Beziehungen zwischen der Morbidität an coronaren Herz-
erkrankungen und Zigarettenrauchen können durch die pharmakologischen Wirkungen des Nikotins allein nicht erklärt werden,
welches auf dem Wege der Freisetzung von Catechinaminen lipolytisch wirkt. Weitere Untersuchungen im Hinblick auf die Beteili-
gung anderer Rauchbestandteile in bezug auf die coronaren Herzerkrankungen sind angezeigt.
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In several retrospective and prospective statistical-
epidcmiological studies, cigarette smoking has been
connected with coronary heart disease (1, 2). In the so
called „Framingham Study" (3) cigarette smoking has
been recognised as a „risk factor", which, together
with other factors, may lead to an earlier manifestation
of coronary heart disease in smokers than in non-
smokers. From a statistical point of view, the relation
between coronary heart disease and cigarette smoking
is not very strong (4), but considering the very high
mortality by coronary heart disease, all risk factors are
of eminent importance. With regard to the influence of
tobacco smoke very little is known about the mechanism,
which may possibly contribute to the manifestation of
coronary heart disease.
In an autoptic study on patients who had died of other
than heart diseases, AUEKBACII (5) showed that smokers
had earlier histoiogically demonstrable manifestations of
coronary sclerosis than non-smokers; moreover the
extent of coronary sclerosis has been stated by AUERBACH
to be correlated with the number of cigarettes consumed.
From these and other investigations it may be concluded,
that the main cause of coronary heart disease is coronary
sclerosis. With regard to the influence of tobacco smoke,
the problem arises as to which constituent of the smoke
f is responsible for the effect described.
Administration of nicotine leads to the release of catecholamincs,
especially from the adrenal medulla. This has been proved by the
finding of increased excretion of catecholamincs and their meta-
bolites in the urine of smokers (6, 7). In addition to the pharma-
cological effects, especially increase of blood pressure, the release
of adrenaline and noradrenaline cause metabolic eflects when
released, namely increase of the blood sugar level and rise of the
concentration of free fatty acids in the blood.
The release of free fatty acids by nicotine via release of caicchol-
amines and subsequent activation of the triglyceride estcrase of
adipose tissue has been shown to occur in experimental animals
(8) and also in humans (9). Because it has been proved, that this
effect takes place also after administration of tobacco smoke we
can assume, that this effect is due to the pharmacological effects
of nicotine.
With regard to these facts, several authors have tried to
evaluate the effect of nicotine on experimental arterio-
sclerosis and on fat metabolism in humans. CZOCHKA-
LYSANOWICS (10), THIENES (11), HASS (12), and GKOSGO-
GEAT (13), using different experimental assays, observed
an increase of arteriosclerotic changes, following the
administration of nicotine to rabbits fed an arteriogcnic
diet.
Several investigators found elevated blood cholesterol
levels after nicotine administration (10, 13, 14). In
humans contradictory results have been obtained;
increased cholesterol levels in smokers have been found
by GOFMAN (15), KARVONEN (16), BRONTE-STEWART (17),
and KANNEL (18). The concentration of /5-lipoprotcins
in the blood of smokers has been found by nearly all
the above authors to be elevated, while the level of
triglycerides in smokers was mostly unchanged (19, 20,
21, 22) or decreased (23,24).
The above mentioned experiments were performed
generally for a relatively short period; nicotine has been
used in addition to other artcriogenic factors, especially
cholesterol feeding. Because of the above mentioned
results and the pharmacological actions of nicotine, we
investigated die effect of nicotine in the rabbit under
the prolonged influence of moderate doses in order to
approximate as closely as possible the conditions of
smoking. The diet was normal and conditions were
constant. At the same time, the biochemical and morpho-
logical effects of chronic nicotine administration were
tested.
Material and Methods
White New Zealand femsilc rabbits aged 40 days were divided
into a nicotine treated group (n ·--- 35) and controls (n ~ 25). At
the end of the experiment (mean life time -- 20 months) 22 ani-
mals of the nicotine treated group and 17 animals of the control
group were still living. 2 months af ter the start of the experiment
several animals fell sick with coccidiosis, Therefore all animals
were treated with a sulfonamidc preparation (Ganda Vit -f D3
4- H) and a vitamin preparation (Vitamin-Komplett Vitamin-
13CK) (both preparations Dr. Rcntschicr & Co,, Laupheim). 3
months later several animals suffered from a ctitnrrhalic infection
of the upper airways which was treated with parenternl applica-
tions of 100 mg chloramphcnicol (Paruxin, Boehringer, Mann-
heim) subcutancously daily*). In addition to the death of some
of these animals we lost some animals from tumors of the stom-
ach, ovaries, and the orbita. Ail animals received "A It romin K"
(firm of Altrogge, Lage, West-Germany) ad libitum as standard
diet without any supplement (composition in %: raw protein 18.2;
raw fibre 13.9; fat 4.9; ash 7.5; N-free extract material 45.2).
Nicotine: The experimental group received 1.14 mg nicotine (free
basc)/kg body weight two times daily from Monday to Friday
and once daily on Saturdays and Sundays in the drinking water.
This dosage was chosen with reference to nicotine amounts ad-
ministered by other authors with subsequent development of
arteriosclerosis and with regard to human smoking behaviour.
The nicotine dose was adapted during the first weeks of the
experiment to the increasing weight of the still growing animals.
Temporary withdrawal of drinking water before administration
of nicotine assured the uptake of the total nicotine dose within
about 30 minutes; moreover, the nicotine concentration in the
blood and in several organs has been estimated in a further group
of animals, undergoing the same treatment (see under "results").
Weight controls were performed monthly.
Fat metabolism: For estimation of fat metabolites, blood was with-
drawn from an ear vein after 8, 10 and 20 months. Withdrawal
of blood was performed always at the same time of day and there-
fore under the same dietetic conditions.
}fre$ fatty acids: Copper method, according to DUNCOMBE (25).
Pbospbolipids: Estimation of organic phosphorus in protein pre-
cipitate according to WACUTUK. (26). Gsterifled fatty acids: Hydrox-
amic acid method of GALBTTI (27). Hound and free cbokskrol with
the LnuiUKMANN-BuRCtiAR'D reaction modified according to WAT-
SON (28). Total lipids: Vanillin method according to CIIAHKOL and
CHAKOUNAT (29). Activity of the lil>oprotcin lifMse as described by
RR and EHISKHAO.HN (30),
Qualitative estimation of the esteriftcd fraction of fatty acids in serum
and organs was performed by gas-chromntogtaphy in n FOLCU-
SPJJURY extract prepared immediately after sacrifice. Moth ylat ion
of fatty acids (SCJILBNK and GELLLUIMANN) (31). Apparatus:
Hewlett-Packard Model 810, FID, metal columns 1/8", length
*) We arc very grateful to Dr. 11. SCIIBI.S, Institut für Mikro-
biologie und Infektionskrankheiten der Tiere der Universität Mün-
chen, for diagnosis and therapeutic suggest ions.
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8 ft. Packing: 10% dicthylsuccinate on chromosorb W, AW-
DMCS, 80 to 100 mesh. Temperature: injection point: 310°,
detector 300°, oven (programmated): 140—190°, 2° per minute,
upper limit 20 minutes. Carrier gas: nitrogen 40 m//minute.
Nicotine estimation was performed by gas-chromatography accord-
ing to a method published earlier by the present authors (32).
Further methods: Serum enzymes: aspartate transaminase (EC
2.6.1.1) (KARMEN (33)), alanine transaminase (EC 2.6.1.2) (WROB-
LEWSKI and LA UE (34)), L-iditol dehydrogenase (sorbitol dehydro-
genase, EC 1.1.1.14) (HOLZER, HAAN and SCHNEIDER (35)), leucine
aminopeptidase (EC 3.4.1.1) (NAGEL, WILLIG and SCHMIDT (36)),
oc-amylase (EC 3.2.1.2) (SOMOGYI (37)), acid phosphatase (EC
3.1.3.2) (FiSHMAN (38)), alkaline phosphatase (EC 3.1.3.1) (BES-
SEY, LOWRY and BROCK (39)), lactate dehydrogenase (EC 1.1.1.27)
(WROBLEWSKI and LAUGE (40)).
Hematologicaland other methods: Erythrocyte-, leucocyte- and throm-
bocyte-counting with counting chamber. Hemoglobin as cyan-
hemiglobin. Estimation of K+, Na+, and Ca++ in the serum with
flame photometer, urea with urease. Blood sugar enzymatically
with the glucose oxidase/peroxidase· method. Serum proteins elec-
trophoretically. Calcium estimation in aortic tissue according to
FERRO and HAM (41).
At the end of the experiment the animals were anesthesized by a
blow on the neck and were bled from the A. carotis. The organs
to be investigated were either removed and deep frozen until
processing, or a FOLCH-SPERRY extract was prepared.
For the estimation of the calcium content and activity of the
lipoprotein. \ipase of aortic tissue, exactly the same part of the
vessel was always used.
Statistical methods: The given problem includes the comparison of
two treatments, namely "nicotine" and "control". Moreover the
effects of the factors "age" and "serum" had to be investigated,
therefore the analysis of variance has been chosen as an appro-
priate statistical model. The analysis of variance requires assump-
tions as follows:
(I) Normally distributed data
(II) Homoscedasticity
(III) Balance of groups
(IV) Independency of data
Assumptions (I) and (II) have been fulfilled by transformation of
the original data. The balance of groups has been produced by
use of random numbers. Independence has been effected by the
method of linear contrast. The effects of treatments have been
considered like fix, the effects of "age" and "serum" as random.
The presentation of results of the analysis of variance renounces
a display of standard deviations.
Some of the data are presented only in tables without the use of
test-procedures. In these tables the standard deviations have been
computed. An estimation with these parameters was not per-
formed; because of the slight deviations of the values the dis-
tributions of the original data have not been checked.
Histological methods: The aorta, main arteries, heart, kidney, liver,
striated muscle, pancreas, intestine, and brain were investigated
microscopically. From some of the animals the adrenals and the
urinary bladder were also investigated. After formalin fixation
(10%) paraffin sections were stained with haematoxylin-eosin.
Results
Body weight
Both groups showed a normal development of body
weight with no difference between the controls and the
nicotine-treated animals. At the end of the experiment
the mean weight of the controls was 4.04 and that of
the nicotine-treated animals 4.22 kg.
Nicotine concentration
The blood of animals treated with nicotine in the same
manner as the experimental group showed in the period
from 15 to 60 minutes after uptake of the whole dose
0.2 to 0.03 μ§ nicotine/m/ blood. A rough balance after
estimation of nicotine in faeces and urine showed that
practically the whole amount administered had been
resorbed and metabolized. From the stomach content,
about 50% were resorbed after 15 minutes: In several
organs, brain, heart, salivary gland, adrenals, and aorta
traces of nicotine could still be detected after 9 hours.
This observed resorprion of nicotine into depots, and
especially into the walls of the blood vessels is in
accordance with findings of other authors (42).
Fat metabolism
Total cholesterol, phosphatides and esterified fatty
acids in the blood rise toward the middle of the
lifetime of the animals and begin to fall towards
the end of the experiment (fig. 1). Because the con-
centration of free cholesterol does not change, the rise
of total cholesterol must be attributed to a change in
the level of cholesterol esters. With regard to age these
changes are statistically significant (P = 0.01). A signi- I „
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ficant difference between test animals and controls of
the same age does not exist. The free fatty acids (fig. 2)
of the serum were increased at the beginning of nicotine
application, moderately elevated after 8 months and in
the range of controls after 20 months. After 20 months
the concentration of the j8-lipoproteins of the test group
(151 mg/100 ml) was higher than that of the controls
(66 mg/100 mf). As these findings are statistically not
significant they must be considered as a chance product.
The values of the lipids in liver, heart, and aorta after
20 months are registered in table 1. There is no difference
between the treated and the control group. Remarkable,
however, is the strongly decreased concentration of
neutral fat in the liver of the nicotine-treated animals.
The concentration of free fatty acids in liver, heart,
and aorta is given in figure 3, which shows that the
concentration of free fatty acids in liver and aorta of
the nicotine-treated group is significantly increased
compared with the controls. The activity of lipoprotein
lipase in aortic tissue of the nicotine treated animals is
significantly higher than that of the controls (fig. 4).
In table 2 the composition of the esterified fatty acids
of aorta, heart, and serum of the experimental animals
is shown. There is no significant difference between
controls and treated animals.
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Free fatty acids in liver heart and aorta at the end of the experiment(20 months). White bars: controls; hatched bars: treated
250
150
50
Q
_
—
-η
S3%
— Ι ι 1 i
8 1Ζ 20
t \month]
Fig. 2
Free fatty acids in the blood after 8, 12 and 20 months. White bars:
controls; hatched bars: treated
400
«? 300
Τ
£ 100
η
— ι ι
Heart Aorta
Fig. 4
Activity of lipoprotein lipase in heart and aorta after 20 months(FFA = free fatty acids). White bars: controls; hatched bars: treated
Tab. 1
Lipids in organs after 20 months, values in mg/100 g fresh weight, neutral fat calculated (means)
Heart
Nicotine Controls
treated
Liver
Nicotine Controls
treated
Aorta
Nicotine Controls
treated
Total lipids
Total cholesterol
Free cholesterol
Esterified fatty acids
Phosphatides
Neutral fat
2779
159
80
1286
1573
1047
2517
152
53
1480
1569
796
3511
433
101
1526
3033
45
3603
393
79
1548
2799
411
9214
291
21
6421
675
8248
9845
353
23
6656
798
8704
Tab. 2
Esterified fatty acids in blood after 20 months. Percentage distribution (means)
Esterified fatty acids
C-Atoms: double bonds
14
16
16:1
18
18:1
18:2
18:3
20:4
22*)
Aorta
Controls
3.01
29.71
6.18
8.11
28.86
19.38
4.37
0.28
Nicotine
1.71
20.03
5.48
8.15
32.96
26.03
3.80
0.93
Controls
2.26
22.70
3.34
11.70
19.97
29.33
2.63
7.99
Heart
Nicotine
1.05
18.30
2.69
11.56
21.68
35.86
2.70
6.54
Controls
0.81
22.00
3.01
11.84
21.80
35.06
2.76
2.64
Serum
Nicotine
0.44
22.25
2.64
10.64
20.23
39.17
2.28
2.24
*) degree of saturation not known.
Z. klin. Chem. u. klin. Biochem. / 8. Jahrg. 1970 / Heft 3 25
194 Schicvcibein, V. Londong, W. Londong, Grumbach, Remplik, Schauer, and Immich: Nicotine and arteriosclerosis
Histopathological findings
Thoracic aorta: In 5 animals the intima showed changes:
Thickening of the intima (3 treated animals), intima
sclerosis (1 treated animal), and atheromatosis (1 control).
Distinct medial sclerosis was found in 5* treated animals
and 3 controls.
Main arteries: Evident medial sclerosis was found in
2 treated animals, the aortas of which were without any
degenerative alterations. In 2 treated animals and
4 controls there was a slight patchy thickening of the
intima. In two cases only the sudan III staining was
unsignificantly positive for lipid deposition in the intima
(1 control and 1 treated animal).
Coronary arteries: Only 2 controls showed alterations
which resembled medial sclerosis. In 15 controls and
9 treated animals perivascular and interstitial lympho-
histiocytic infiltrations of various degree were found.
In these sections alterations of coronary arteries with
respect to intima proliferation could not be ob-
served.
Renal arteries: 10 controls and 5 treated animals showed
arteriolosclerosis, occasionally combined with slight
arteriosclerosis.
Cerebral arteries: In 7 controls and 11 treated animals
perivascular round cell infiltration was present.
Other organs: Liver sections of most animals (17 controls
and 22 treated animals) showed round cell infiltrations
in the periportal fields; in some animals proliferation of
the bile ducts and centrolobular hyperaemia could be
observed. In addition in 3 controls and 1 treated animal
there was a diffuse and fine vacuolar fatty change of the
liver. Degenerative alterations of the hepatic vessels
could not be seen except for one case of subendothelial
amyloidosis which was also found in the renal glomerula.
Tubular nephrosis was found relatively often (7 controls
and 12 treated animals) with reabsorbed pigment in the
tubular epithelium and with intratubular calcification.
In 19 animals (11 controls and 8 treated animals) inter-
stitial round cell infiltrations were observed, sometimes
combined with the above mentioned tubular nephrosis.
The epithelium of the urinary bladder of only 4 controls
was changed as in catarrhalic cystitis. Striated muscle
of 1 control showed intramuscular calcification.
No remarkable changes were found in the sections of
adrenal glands, pancreas, and intestine.
Further results
The calcium content of the aorta of the test group is
significantly increased compared with the controls
(fig- 5).
Table 3 shows the activities of several serum enzymes
at the time of sacrifice of the animals. An increased
activity of the amylase, acid phosphatase and cholin-
esterase and a decrease of the activity of lactate dehydro-
genase in the treated animals can be seen. These changes,
however, are statistically not significant and are within
the normal range, when human values are taken for
comparison.
A summary of the blood cell counts is given in tables 4
and 5, there are no differences, except for a small
20-
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Fig. 5 .
Calcium content in aorta after 20 months. White bars: controls;
hatched bars: treated
Tab. 3
Serum enzymes after 20 months (means ± SD)
Enzyme mU/m/
amylase
acid phosphatase
cholinesterase
lactate dehydrogenase
leucine amino peptidase
sorbitol dehydrogenase
alanine transaminase
aspartate transaminase
alkaline phosphatase
Nicotine-treated
animals
404 ± 156(n = 15)
31.3 ± 18.8(n - 18)
1.4 ± 0.3
(n - 18)
44.8 ± 6.9(n = 18)
18.2 ± 1.6
(n = 18)
6.4 ± 1.4
(n = 18)
10.0 ± 2.5(n = 18)
12.8 = 5.7(n = 17)
19.0 ± 13(n = 18)
Control animals
272 ± 176(n - 12)
21.4 ±6.5(n =* 12)
0.76 ± 0.2(n - 12)
73.2 ± 33.6
(n = 11)
21.6 ±6.9
(n = 11)
4.7 ± 1.9(n = 12)
11.7 ±3.5(n = 12)
10.9 ± 2.8
(n == 12)
18.0 ± 7.3(n - 12)
Tab. 4
Erythrocytes, blood platelets, hemoglobin and hematocrit after 20
months (means ± SD)
Subject
erythrocyte count
millions per mm8 blood
hemoglobin
g/100 ml blood
volume of
erythrocytes μηι3
hematocrit
Vol. %
hemoglobin content of
single erythrocyte pg
blood platelets count
in 1000/mm8
Nicotine-treated
animals
4.3 ± 1.2(n = 17)
11.5 ± 1.1(n = 17)
90.7 ± 57.0(n - 17)
34.3 ± 5.4(n - 17)
30.6 ±21.0(n = 17)
408.6 ± 123.2(n - 18)
Control animals
4.4 ± 0.8(n - 12)
11.4 ±0.7(n - 12)
81.0 ± 20.0(n - 12)
35.6 ± 10.8(n = 12)
26.1 ±4.4(n = 12)
391.7 ± 78.3(n - 13)
Tab. 5
Granulocytes, percentage distribution after 20 months (means)
Leucocytes
leucocytes count
in 1000 per mm* blood
segmented cells
mature segmented
lymphocytes
eosinophiles
monocytes
basophiles
Nicotine-treated
animals
3.9
0
21.1
76.4
1.4
1.0
0
Control animals
2.9
0.5
8.8
84.2
4.4
2.0
0
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Tab. 6
Composition of serum proteins after 20 months (means and range)
Test groups
control group (n = 13)
nicotine-treated animals (n « 17)
Albumin
rel.-%
66
59—71
60
29—68
.*·rel.-%
6
4—11
6
2—10
«a
6
4—9
7
3—24
Globulins
β
10
7—12
11
8—23
y
rel.-%
16
10—20
16
11—23
y
g/100 ml
1
0.65—1.34
1
0.54—1.41
Total
protein
g/100 ml
6.3
5.1—6.7
5.9
4.9—7.1
increase in segmented cells in the nicotine-treated group.
Table 6 gives the composition of the serum proteins. The
total protein is lower in the test group, obviously
dependent on a decrease of the globulins. The concentra-
tions of electrolytes, urea, and blood sugar of the test
group resembled those of the controls (table 7). All these
findings have, because of the slight deviations, as already
mentioned, not been statistically tested. Therefore any
kind of generalization seems to be impossible.
Tab. 7
Electrolytes, urea and blood sugar after 20 months (means ± so)
blood component
calcium mval/J
sodium mval/J
potassium mval/f
urea mg/100 ml
blood sugar mg/100 ml
Nicotine-treated
animals
6.9 db 0.5(n - 16)
143 db 4.2(n= 16)
4.7 ± 0.7(n - 16)
29.7 db 17.9(n - 15)
229 ± 73(n - 16)
Control group
6.9 ± 0.4(n - 12)
141 ± 1.6(n - 12)
4.3 ± 0.7(n = 12)
24.4 ±5.1(n - 12)
207 db 56(n - 10)
Discussion
Nicotine dosage and concentration
Depending on methodical difficulties, there exist very
few observations on the amount of nicotine absorbed
from tobacco smoke by the human organism. From
animal experiments and from nicotine estimations in
human blood we can conclude that an average of not
more than 1 mg nicotine may be resorbed from one
cigarette by inhaling (43). Under this assumption the
nicotine dose used in this experiment would correspond
to the dose a smoker is inhaling who smokes more
than 100 cigarettes daily. Although the dosage used in
this experiment is definitively lower than in most
earlier investigations, it should be remembered that this
dose is higher than can be expected even by heavy
smokers.
Fat metabolism
The composition of blood fat shows a statistically
significant alteration according to age, but no difference
between controls and nicotine treated animals. The
results with regard to the concentration of free fatty
acids in serum are in fact statistically not significant,
but seem to be worth repeating, because of the
finding that the activity of the lipoprotein lipase of
aortic tissue in the nicotine-treated animals is signifi-
cantly elevated and these conditions may be an adap-
tation to increased lipolytic activity.
As mentioned already, nicotine has a marked lipolytic
effect via release of catecholamines. This has been proved
in our own experiments (44) and by KERSHBAUM and
coworkers (9). This fact can explain the high concentra-
tion of free fatty acids in the serum and in organs, as
well as the decrease of the concentration of neutral fat,
especially in the liver. Nicotine therefore does not
promote lipoidosis, on the contrary, it releases free
fatty acids from triglycerides, according to its above
mentioned metabolic actions. These results are in
accordance with findings of CUNNINGHAM and FRIEND
(45), who showed that the meat from nicotine treated
pigs is protein-rich and poor in fat.
For the first time, we were able to show an increased
activity of the lipoprotein lipase in heart and aorta
under the influence of nicotine. This result seems to be
an important point for further investigation. The
activity of this enzyme in the blood of the nicotine-
treated animals could not be estimated, because of the
very low activity of the enzyme if not stimulated by
heparin. Heparinization could not be performed because
of the possible influence of heparin on other parameters
to be measured.
It has been assumed, that a chronically elevated level of
free fatty acids in the blood may lead to an elevated
level of cholesterol via the /?-oxidation of free fatty acids
and subsequent disposition of C-2 compounds for
cholesterol synthesis. Our results do not favor this
theory.
Our results are in accordance with findings of GUD-
BJARNASON (46), who, after nicotine administration to
dogs, found basically the same results especially with
regard to the concentration of fat metabolites in serum
and organs. He moreover found an inhibition of
cholesterol synthesis by nicotine and a significant pro-
longation of the half life of administered cholesterol in
the nicotine treated animals.
Our results may explain the surprising results of other
authors, mentioned in the introduction, that the level
of triglycerides in the blood is decreased in smokers in
long time and acute experiments. The increase of the
activity of lipoprotein lipase may be the explanation of
this phenomenon.
Etiology of arteriosclerosis
Our results show, that nicotine alone does not produce
a lipoidosis even after prolonged administration to
animals, who tend to spontaneous development of arterio-
sclerosis of the main arteries. On the contrary, nicotine
acts lipolytically in accordance to its known pharma-
cological effect. ZEMPLUNYI and coworkers (47) showed
in rabbits an increased lipolytic activity in aortic tissue
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after cholesterol feeding; thus increased lipolytic activity
does not seem to exclude sclerosis. The increase in
the activity of lipoprotein lipase may be a consequence
of a disturbed metabolism of the aortic wall which
seems to be the case during sclerosation and which
could be shown in several investigations on enzymes
of the sclerotic vessel (for references see PLATT (48)).
A very important finding in the present investigation is
the significantly elevated calcium content of the aorta
of the nicotine-treated animals, with no increase in the
calcium concentration of the serum. Further investiga-
tions will be needed to confirm and to evaluate the
mechanism of this finding. However, it seems that
alterations in arterial tissues are biochemically de-
monstrable before changes can be shown histologically
and that the estimation of the calcium content is a useful
method for the estimation of the degree of calcification.
Correlation between smoking and coronary heart disease
Our results do supply some evidence for a possible
participation of nicotine in an earlier manifestation of
coronary heart disease in smokers. But considering the
amount of nicotine administered in this experiment and
possible differences in resorption between smokers and
our experimental conditions, it seems to us not very
likely that nicotine alone represents the "risk factor
smoking" in coronary heart disease. In this connection,
a paper by HESS and FROST (49) may be of some im-
portance. These-authors demonstrated alterations in
aortic intima with a new electron microscopic technique
in rabbits after relatively short exposure to tobacco
smoke and confirmed with these findings earlier results
of SHIMAMOTO (50). It seems possible, that a prolonged
nicotine action may produce calcification in tussues,
altered by other constituents of tobacco smoke; there-
fore, further substances should be sought in tobacco
smoke, which may be connected with this problem. In
this connection, results of ASTRUP and coworkers (51)
should be mentioned, who found heavy arterisclerotic
alterations in the coronary arteries of rabbits, exposed
to cholesterol feeding and an elevated concentration of
carbon monoxide in the respiration air.
With regard to the toxicity of chronic nicotine admini-
stration, no indication of damage to organ systems has
been found; especially noteworthy is the absence of patho-
logical values for serum enzymes. TJAWOKIN (52) found
an increased value of aspartate transaminase. We did
not observe a change in aspartate transaminase activity,
which correlates with the absence of histologicalfindings,
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